Hideomi Watanabe

FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions

Jun Aoki, Hideomi Watanabe, Tetsuya Shinozaki et al. · Radiology · 2001 · 318 citations

Medicine, Nuclear Medicine, Oncology +17

Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.

Yasufumi Niinaka, S Paku, Akihiro Haga et al. · PubMed · 1998 · 141 citations

Medicine, Cell Biology, Oncology +14

Identification of B16-F1 melanoma autocrine motility-like factor receptor.

Ivan R. Nabi, Hideomi Watanabe, Avraham Raz · PubMed · 1990 · 134 citations

Life Sciences, Cell Biology, Oncology +12

The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein¹

Kimihiro Shimizu, Masachika Tani, Hideomi Watanabe et al. · FEBS Letters · 1999 · 119 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor

Keizo Taniguchi, Y Yonemura, N Nojima et al. · Cancer · 1998 · 113 citations · Full text

Medicine, Cancer Biology, Oncology +14